6.
Lewis T, Shapiro P, Ahn N
. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998; 74:49-139.
DOI: 10.1016/s0065-230x(08)60765-4.
View
7.
Friedemann T, Otto B, Klatschke K, Schumacher U, Tao Y, Leung A
. Coptis chinensis Franch. exhibits neuroprotective properties against oxidative stress in human neuroblastoma cells. J Ethnopharmacol. 2014; 155(1):607-15.
DOI: 10.1016/j.jep.2014.06.004.
View
8.
Wu J, Nakashima S, Shigyo M, Yamasaki M, Ikuno S, Morikawa A
. Antihypertensive constituents in Sanoshashinto. J Nat Med. 2020; 74(2):421-433.
PMC: 7929964.
DOI: 10.1007/s11418-019-01382-9.
View
9.
Singh S, Srivastav S, Castellani R, Plascencia-Villa G, Perry G
. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019; 16(3):666-674.
PMC: 6694352.
DOI: 10.1007/s13311-019-00767-8.
View
10.
Tahamtan M, Allahtavakoli M, Abbasnejad M, Roohbakhsh A, Taghipour Z, Taghavi M
. Exercise preconditioning improves behavioral functions following transient cerebral ischemia induced by 4-vessel occlusion (4-VO) in rats. Arch Iran Med. 2013; 16(12):697-704.
DOI: 0131612/AIM.004.
View
11.
Kitagawa K, Matsumoto M, Yang G, Mabuchi T, Yagita Y, Hori M
. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab. 1998; 18(5):570-9.
DOI: 10.1097/00004647-199805000-00012.
View
12.
Lai T, Zhang S, Wang Y
. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2013; 115:157-88.
DOI: 10.1016/j.pneurobio.2013.11.006.
View
13.
Widmann C, Gibson S, Jarpe M, Johnson G
. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999; 79(1):143-80.
DOI: 10.1152/physrev.1999.79.1.143.
View
14.
Jung W, Kwon S, Cho S, Park S, Moon S, Park J
. The Effects of Chunghyul-Dan (A Korean Medicine Herbal Complex) on Cardiovascular and Cerebrovascular Diseases: A Narrative Review. Evid Based Complement Alternat Med. 2016; 2016:2601740.
PMC: 4909900.
DOI: 10.1155/2016/2601740.
View
15.
Stebbins G, Nyenhuis D, Wang C, Cox J, Freels S, Bangen K
. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008; 39(3):785-93.
DOI: 10.1161/STROKEAHA.107.507392.
View
16.
Lee B, Choi Y, Kim H, Kim S, Hahm D, Lee H
. Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life Sci. 2003; 74(4):435-50.
DOI: 10.1016/j.lfs.2003.06.034.
View
17.
Sarti C, Pantoni L, Bartolini L, Inzitari D
. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci. 2002; 203-204:263-6.
DOI: 10.1016/s0022-510x(02)00302-7.
View
18.
Wang M, Hayashi H, Horinokita I, Asada M, Iwatani Y, Liu J
. Neuroprotective effects of Senkyunolide I against glutamate-induced cells death by attenuating JNK/caspase-3 activation and apoptosis. Biomed Pharmacother. 2021; 140:111696.
DOI: 10.1016/j.biopha.2021.111696.
View
19.
Kalaria R, Maestre G, Arizaga R, Friedland R, Galasko D, Hall K
. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008; 7(9):812-26.
PMC: 2860610.
DOI: 10.1016/S1474-4422(08)70169-8.
View
20.
Candas D, Li J
. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal. 2013; 20(10):1599-617.
PMC: 3942709.
DOI: 10.1089/ars.2013.5305.
View